In cancer, CNDP2 has been observed to activate the PI3K/AKT [67] and MAPK signalling pathways [72], upregulate key cell cycle proteins (e.g. cyclin E, cyclin B1) [68] and interact with pepsinogen C [73]. The gene discussed is CNDP2; the disease is cancer.